NCT04439838View on ClinicalTrials.gov

A Study in Healthy Men to Test How Different Doses of BI 1595043 Are Tolerated

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 13, 2020

Primary Completion Date

March 19, 2021

Study Completion Date

March 19, 2021

Conditions
Healthy
Interventions
DRUG

BI 1595043

BI 1595043

DRUG

Placebo

Placebo

Trial Locations (1)

2650

SGS Life Science Services - Clinical Research, Edegem

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04439838 - A Study in Healthy Men to Test How Different Doses of BI 1595043 Are Tolerated | Biotech Hunter | Biotech Hunter